Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus

Hunain Raza; Muhammad E Bhutta; Muhammad H Siddique

doi:10.18295/squmj.8.2024.050

Section Letters to the Editor

Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus

https://doi.org/10.18295/squmj.8.2024.050

Hunain Raza

Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan

Muhammad E Bhutta

muhammad.eeman59@gmail.com (Primary Contact)

Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan

Muhammad H Siddique

Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan

Download

PDF

Statistic

Read Counter : 191 Download : 164

Downloads

Download data is not yet available.

Abstract

NONE

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

How to Cite

Raza, H., Bhutta, M. E., & Siddique, M. H. (2024). Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus. Sultan Qaboos University Medical Journal, 24(3), 418–419. https://doi.org/10.18295/squmj.8.2024.050

Download Citation

Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus

Article Sidebar

Downloads

Main Article Content

Abstract

Article Details